Calamos Advisors LLC Boston Scientific Corp Transaction History

Calamos Advisors LLC

$15.7 Billion
Q1 2025

A detailed history of Calamos Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Calamos Advisors LLC holds 969,968 shares of BSX stock, worth $101 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

969,968

Previous 1,027,057 5.56%

Holding current value

$101 Million

Previous $91.7 Million 6.66%

% of portfolio

0.62%

Previous 0.55%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	SELL	$89.38 - $106.18 $5.1 Million - $6.06 Million	-57,089 Reduced 5.56%	969,968 $97.9 Million
Q4 2024 Jan 24, 2025	BUY	$83.62 - $91.5 $377,042 - $412,573	4,509 Added 0.44%	1,027,057 $91.7 Million
Q3 2024 Nov 07, 2024	SELL	$72.96 - $84.0 $683,197 - $786,576	-9,364 Reduced 0.91%	1,022,548 $85.7 Million
Q2 2024 Jul 25, 2024	SELL	$67.33 - $77.71 $3.42 Million - $3.94 Million	-50,741 Reduced 4.69%	1,031,912 $79.5 Million
Q1 2024 May 08, 2024	SELL	$57.6 - $68.62 $2.18 Million - $2.6 Million	-37,911 Reduced 3.38%	1,082,653 $74.2 Million
Q4 2023 Jan 31, 2024	SELL	$48.64 - $57.81 $240,232 - $285,523	-4,939 Reduced 0.44%	1,120,564 $64.8 Million
Q3 2023 Oct 25, 2023	BUY	$50.19 - $54.68 $125,424 - $136,645	2,499 Added 0.22%	1,125,503 $59.4 Million
Q2 2023 Jul 28, 2023	BUY	$49.72 - $54.64 $2.14 Million - $2.35 Million	42,983 Added 3.98%	1,123,004 $60.7 Million
Q1 2023 May 03, 2023	SELL	$45.09 - $50.03 $5.8 Million - $6.44 Million	-128,640 Reduced 10.64%	1,080,021 $54 Million
Q4 2022 Jan 25, 2023	SELL	$39.56 - $47.22 $4.45 Million - $5.31 Million	-112,498 Reduced 8.52%	1,208,661 $0
Q3 2022 Oct 24, 2022	SELL	$36.71 - $109.66 $111,084 - $331,831	-3,026 Reduced 0.23%	1,321,159 $51.2 Million
Q2 2022 Aug 01, 2022	BUY	$35.24 - $47.1 $3.6 Million - $4.81 Million	102,122 Added 8.36%	1,324,185 $49.4 Million
Q1 2022 May 03, 2022	BUY	$40.9 - $45.1 $4.31 Million - $4.76 Million	105,492 Added 9.45%	1,222,063 $54.1 Million
Q4 2021 Feb 01, 2022	BUY	$38.07 - $44.87 $816,373 - $962,192	21,444 Added 1.96%	1,116,571 $47.4 Million
Q3 2021 Oct 26, 2021	SELL	$41.23 - $45.88 $2.28 Million - $2.54 Million	-55,354 Reduced 4.81%	1,095,127 $47.5 Million
Q2 2021 Jul 22, 2021	BUY	$38.58 - $44.24 $5.4 Million - $6.19 Million	139,973 Added 13.85%	1,150,481 $49.2 Million
Q1 2021 Apr 12, 2021	BUY	$35.27 - $39.67 $9.89 Million - $11.1 Million	280,323 Added 38.39%	1,010,508 $39.1 Million
Q4 2020 Jan 27, 2021	BUY	$33.15 - $41.97 $638,369 - $808,216	19,257 Added 2.71%	730,185 $26.3 Million
Q3 2020 Oct 26, 2020	SELL	$34.44 - $42.23 $1.6 Million - $1.96 Million	-46,405 Reduced 6.13%	710,928 $27.2 Million
Q2 2020 Jul 27, 2020	SELL	$30.19 - $39.11 $11.7 Million - $15.2 Million	-389,033 Reduced 33.94%	757,333 $26.6 Million
Q1 2020 Apr 28, 2020	BUY	$25.83 - $45.71 $23.1 Million - $40.8 Million	893,345 Added 353.07%	1,146,366 $37.4 Million
Q4 2019 Jan 15, 2020	SELL	$37.87 - $45.37 $299,665 - $359,012	-7,913 Reduced 3.03%	253,021 $11.4 Million
Q3 2019 Oct 21, 2019	BUY	$40.31 - $43.45 $10.5 Million - $11.3 Million	260,934 New	260,934 $10.6 Million

Others Institutions Holding BSX

# of Institutions

1,832

Shares Held

1.21B

Call Options Held

9.66M

Put Options Held

6.98M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $149B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Boston Scientific Corp Transaction History